Research powered investment banking
Home
Research
Companies
Themes
Top Picks
Transactions
Events
Redeye
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
Posts
Investor Scoring
sign in
Member sign in
Join redeye
Home
research
Companies
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
community
Posts
Investor Scoring
The latest from Redeye about Scandinavian Life Science and Technology companies
Isofol Medical
Q1: Eventful months
Bong
A little brighter outlook
Clavister Holding
Building a security platform
Promore Pharma
Intervju med vd Jonas Ekblom (video)
Envirotech Seminar
Watch the replay here
Bioinvent International
No drama in Q1 - key milestones approaching
Promore Pharma
A somewhat more optimistic tone in Q1
THQ Nordic
First comment Q5, beating estimates again
Better Collective
Analyst interview with Jonas Amnesten
Premium
Top Picks
Köper växande kvalitetsbolag
Isofol Medical
Strengthened IP Protection
IMINT Image Intelligence
Q1’19: Weak quarter as expected
Sivers IMA
Q1’19: High sales growth
Nuevolution
Here comes the sun
Transactions
08
May
Alelion genomför fullt garanterad förträdesemission
14
May
TagMaster genomför riktad nyemission och företrädesemission
15
May
Episurf Medical genomför nyemission
Events
24
May
Gaming Day
28
May
Pre-ASCO Seminar
10
Jun
Growth Day
13
Jun
Tobii: Live Investor Presentation & Q&A
13
Jun
Tobii: Investor Presentation
Announcements
New accounting principle to affect upcoming interim reports
Redeye söker Projektledare inom Corporate Finance
Redeye sponsrar integrationsprojektet Näringslivet Möter Förorten